Patents Assigned to Deltagen Proteomics
  • Patent number: 6623922
    Abstract: The invention provides methods for efficient and rapid identification of cis-acting nucleic acid sequences that act in a cell-type specific manner to stimulate or repress the expression of linked genes or other neighboring sequences. The invention also provides methods for evolving novel regulatory sequences by in vitro manipulation of naturally occurring or synthetic cis acting nucleic acid sequences followed by screening and counterscreening steps. Furthermore, the invention provides methods for determining the mechanism by which cell-type specific cis regulatory sequences confer cell-type specific expression. Also provided are diagnostic methods based on the use of cell-type specific cis regulatory sequences.
    Type: Grant
    Filed: February 14, 1997
    Date of Patent: September 23, 2003
    Assignee: Deltagen Proteomics
    Inventors: Carl Alexander Kamb, Giordano M. Caponigro